HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liming Wang Selected Research

Zinc Finger Nucleases

1/2020The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells.
1/2018Withdrawal Notice: Zinc Finger Nuclease Combines with Cisplatin and Trichostatin A Enhances the Antitumor Potency in Cervical Cancer Cells
12/2014Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liming Wang Research Topics

Disease

99Neoplasms (Cancer)
08/2022 - 01/2002
40Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2012
20Inflammation (Inflammations)
07/2022 - 01/2009
18Neoplasm Metastasis (Metastasis)
09/2021 - 01/2014
16Carcinogenesis
01/2022 - 06/2007
16Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 12/2014
10Infections
04/2022 - 05/2002
10Osteoarthritis
01/2022 - 01/2015
10Esophageal Neoplasms (Esophageal Cancer)
02/2016 - 01/2013
8Fibrosis (Cirrhosis)
07/2022 - 01/2009
8Breast Neoplasms (Breast Cancer)
12/2021 - 01/2007
8Albuminuria
11/2021 - 12/2005
7Proteinuria
11/2021 - 12/2005
7Adenocarcinoma
07/2021 - 01/2002
7Diabetic Nephropathies (Diabetic Nephropathy)
12/2019 - 08/2011
6Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 01/2015
6Necrosis
11/2021 - 01/2008
6Cholangiocarcinoma
09/2021 - 06/2014
6Liver Neoplasms (Liver Cancer)
11/2020 - 08/2014
6Hypoxia (Hypoxemia)
10/2018 - 02/2012
5Hemorrhage
06/2022 - 08/2017
5Pancreatitis
06/2022 - 12/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2017
5Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
11/2021 - 02/2012
5Acute Lung Injury
01/2020 - 11/2013
4Prostatic Neoplasms (Prostate Cancer)
05/2022 - 01/2002
4Lung Injury
01/2022 - 11/2013
4Hypertrophy
01/2022 - 07/2014
4Melanoma (Melanoma, Malignant)
01/2021 - 11/2007
4Rheumatoid Arthritis
01/2021 - 12/2013
4Starvation
10/2020 - 04/2015
4Body Weight (Weight, Body)
11/2019 - 01/2009
4Arthritis (Polyarthritis)
01/2019 - 01/2008
3Acute Kidney Injury (Acute Renal Failure)
01/2022 - 07/2009
3Pain (Aches)
01/2022 - 01/2020
3Corneal Injuries
01/2022 - 11/2017
3Reperfusion Injury
01/2022 - 01/2014
3Myocardial Infarction
04/2021 - 04/2008
3Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 01/2017
3Kidney Diseases (Kidney Disease)
01/2021 - 01/2008
3Liver Diseases (Liver Disease)
01/2021 - 03/2014
3Carcinoma (Carcinomatosis)
10/2020 - 04/2002
3Disease Progression
10/2020 - 04/2002
3Nephrosis
12/2019 - 01/2008
3Compression Fractures (Compression Fracture)
08/2019 - 04/2009
3Osteosarcoma (Osteogenic Sarcoma)
06/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
14Pharmaceutical PreparationsIBA
08/2022 - 05/2013
14MicroRNAs (MicroRNA)IBA
07/2021 - 01/2013
13Biomarkers (Surrogate Marker)IBA
11/2022 - 04/2013
10CytokinesIBA
01/2022 - 10/2007
9Long Noncoding RNAIBA
05/2022 - 01/2017
9Messenger RNA (mRNA)IBA
01/2022 - 01/2002
8Therapeutic UsesIBA
01/2022 - 01/2008
8Small Interfering RNA (siRNA)IBA
01/2022 - 05/2016
8GoldIBA
11/2021 - 02/2011
7Cisplatin (Platino)FDA LinkGeneric
01/2020 - 01/2015
6HMGB1 Protein (HMG1)IBA
06/2022 - 06/2020
6InterleukinsIBA
01/2022 - 01/2008
6Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2006
5Metformin (Glucophage)FDA LinkGeneric
05/2022 - 06/2014
5AntigensIBA
01/2022 - 11/2007
5Puromycin AminonucleosideIBA
11/2021 - 12/2005
5Biological ProductsIBA
01/2021 - 09/2013
5SteroidsIBA
04/2020 - 03/2008
5Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 01/2015
5TRPC6 Cation ChannelIBA
12/2019 - 02/2012
5CaspasesIBA
11/2014 - 04/2003
4CollagenIBA
07/2022 - 11/2013
4ChromatinIBA
01/2022 - 01/2017
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018
4InflammasomesIBA
01/2022 - 01/2019
4Protein Isoforms (Isoforms)IBA
01/2021 - 05/2016
4RNA (Ribonucleic Acid)IBA
01/2020 - 01/2015
4Phosphotransferases (Kinase)IBA
01/2020 - 08/2014
3Peptide Hydrolases (Proteases)FDA Link
01/2022 - 01/2014
3CopperIBA
01/2022 - 08/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2021 - 04/2003
3Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 01/2018
3Urea (Carbamide)FDA LinkGeneric
12/2021 - 10/2020
3CreatinineIBA
12/2021 - 06/2011
3Antiviral Agents (Antivirals)IBA
07/2021 - 01/2016
3EnzymesIBA
01/2021 - 02/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 02/2016
3Zinc Finger NucleasesIBA
01/2020 - 12/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 10/2008

Therapy/Procedure

36Therapeutics
01/2022 - 01/2008
15Drug Therapy (Chemotherapy)
01/2022 - 03/2013
13Hepatectomy
09/2021 - 01/2012
9Radiotherapy
01/2021 - 08/2012
6Transplantation
01/2019 - 03/2008
5Precision Medicine
01/2019 - 03/2012
4Length of Stay
06/2022 - 07/2009
4Adjuvant Radiotherapy
10/2020 - 03/2014
4Photothermal Therapy
01/2016 - 04/2014
3Peritoneal Dialysis
11/2022 - 01/2020
3Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 12/2014
3Injections
01/2022 - 01/2008
3Neoadjuvant Therapy
01/2020 - 01/2014
3Kyphoplasty
08/2019 - 04/2009